Details for New Drug Application (NDA): 214616
✉ Email this page to a colleague
The generic ingredient in FOSAPREPITANT DIMEGLUMINE is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
Summary for 214616
Tradename: | FOSAPREPITANT DIMEGLUMINE |
Applicant: | Aspiro |
Ingredient: | fosaprepitant dimeglumine |
Patents: | 0 |
Suppliers and Packaging for NDA: 214616
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 214616 | ANDA | NorthStar RxLLC | 16714-248 | 16714-248-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 214616 | ANDA | Camber Pharmaceuticals, Inc. | 31722-165 | 31722-165-31 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31) / 5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 150MG BASE/VIAL | ||||
Approval Date: | Jul 29, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription